Inactive Instrument

Calendar TapImmune Inc. Other OTC

Equities

US8760333091

End-of-day quote Other OTC
- USD - Intraday chart for TapImmune Inc.

Chart calendar TapImmune Inc.

0.YM9gXeMJr8KKVr8atxeE57ZeFTaiuKrkfBAPliiu9hY.OIABZNY6wfT8Gox3hCep1-YqRFHhyem1FEhnu33mwkVRhhEW2m-dm8IG_g~548c97bf98b56a2e76ca6e3c9f1c66d3

Upcoming events on TapImmune Inc.

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-12 Q4 2024 Earnings Release (Projected)

Past events on TapImmune Inc.

2024-04-01 Hematologic Malignancies Global Summit
2024-03-26 10:00 am H.C. Wainwright Cell Therapy Virtual Conference
2024-03-25 05:45 pm Q4 2023 Earnings Release
2024-01-09 Non Dilutive Funding Summit
2024-01-07 Biotech Showcase
2023-11-09 05:00 pm Q3 2023 Earnings Release
2023-09-13 08:30 am H.C. Wainwright Global Investment Conference
2023-08-14 04:30 pm Q2 2023 Earnings Release
2023-06-06 09:00 am Annual General Meeting
2023-03-22 08:10 am Q4 2022 Earnings Release
2022-11-10 04:05 pm Q3 2022 Earnings Release
2022-09-15 09:20 am Cantor Fitzgerald Cell & Gene Therapy Conference
2022-08-11 04:22 pm Interim 2022 Earnings Release
2022-05-24 09:00 am Annual General Meeting
2022-05-13 07:00 am Q1 2022 Earnings Release
2022-05-05 08:45 pm International Society for Cell & Gene Therapy Meeting - Abstract Number : 506
2022-05-05 08:45 pm International Society for Cell & Gene Therapy Meeting - Abstract Number : 936
2022-05-05 08:45 pm International Society for Cell & Gene Therapy Meeting - Abstract Number : 515
2022-05-05 08:45 pm International Society for Cell & Gene Therapy Meeting - Abstract Number : 937
2022-03-17 05:45 pm FY 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022
Net sales
Million USD
Released
Forecast
Spread
0,21
0,00
-
0,47
0,48
-3.46%
1,24
0,00
-
9,01
9,00
0.15%
EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-22,5
-23,2
2.92%
-28,9
-27,8
-3.86%
-39,5
-40,5
2.49%
0,00
0,00
-
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-21,4
-22,2
3.26%
-28,7
-27,7
-3.56%
-41,9
-42,3
0.95%
0,00
0,00
-
Net income
Million USD
Released
Forecast
Spread
-21,4
-22,2
3.26%
-28,7
-27,7
-3.56%
-41,9
-42,3
0.95%
0,00
0,00
-
EPS
USD
Released
Forecast
Spread
-4,70
-4,86
3.29%
-6,10
-5,90
-3.39%
-5,50
-5,73
3.93%
-3,58
-3,60
0.56%
Announcement Date12/03/2009/03/2117/03/2222/03/23

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales
Million USD
Released
Forecast
Spread
1,24
0,00
-
0,96
0,00
-
0,79
2,50
-68.38%
3,95
0,27
1381.07%
3,31
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-9,76
-10,8
9.21%
-9,79
-11,2
12.55%
-9,28
-8,72
-6.46%
-7,02
-11,3
37.7%



Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-9,76
-10,8
9.38%
-9,91
-11,2
11.25%
-9,24
-8,74
-5.81%
-6,92
-10,9
36.23%



Net income
Million USD
Released
Forecast
Spread
-9,76
-10,8
9.38%
-9,91
-11,2
11.25%
-9,24
-8,74
-5.81%
-6,92
-10,9
36.23%



EPS
USD
Released
Forecast
Spread
-1,10
-1,28
13.73%
-1,20
-1,33
10%
-1,10
-1,05
-4.76%
-0,80
-1,30
38.46%
-3,27
-1,00
-227%
Announcement Date17/03/2213/05/2211/08/2210/11/2222/03/23